Literature DB >> 2999106

Purification of an active opioid-binding protein from bovine striatum.

T L Gioannini, A D Howard, J M Hiller, E J Simon.   

Abstract

We report the purification to apparent homogeneity of an active opioid-binding protein solubilized from bovine striatal membranes. The purification was accomplished in two steps: affinity chromatography on beta-naltrexylethylenediamine (NED)-CH-Sepharose 4B followed by lectin affinity chromatography on wheat germ agglutinin-agarose. The ligand affinity-purified fraction exhibits stereospecific and saturable binding of opiates and is heat-sensitive. Polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate of the NED-purified material gave 6-8 bands by silver staining or autoradiography of radioiodinated material. Under nondenaturing conditions, the NED-purified material elutes in a molecular mass range between 300 and 350 kDa from gel exclusion chromatography on Ultrogel AcA-34. The specific activity of the affinity-purified fraction (800-1500 pmol/mg protein) is enriched 4000 to 7000-fold over that of the membrane-bound or unpurified soluble receptor. Further purification (10-20-fold) is achieved by chromatography of the NED eluate on wheat germ agglutinin-agarose. The eluted fraction shows a single protein (65 kDa) on sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The purified material is an acidic glycoprotein with a pI of 6.0-6.3 and binds opiates with a specific activity (12,000-15,000 pmol/mg) that is 65,000 to 75,000-fold greater (theoretical, 77,000-fold) than that of the membrane-bound or crude soluble receptors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2999106

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  The Neurobiology of Addiction: Where We Have Been and Where We Are Going.

Authors:  George F Koob; Eric J Simon
Journal:  J Drug Issues       Date:  2009-01

2.  Inactivation of the purified bovine mu opioid receptor by sulfhydryl reagents.

Authors:  T L Gioannini; I Onoprishvili; J M Hiller; E J Simon
Journal:  Neurochem Res       Date:  1999-01       Impact factor: 3.996

Review 3.  The structure and mechanism of neurotransmitter receptors. Implications for the structure and function of the central nervous system.

Authors:  P G Strange
Journal:  Biochem J       Date:  1988-01-15       Impact factor: 3.857

Review 4.  The next frontier in the molecular biology of the opioid system. The opioid receptors.

Authors:  O Civelli; C Machida; J Bunzow; P Albert; E Hanneman; J Salon; J Bidlack; D Grandy
Journal:  Mol Neurobiol       Date:  1987       Impact factor: 5.590

5.  Inhibition of dopamine-sensitive adenylate cyclase by opioids: possible involvement of physically associated mu- and delta-opioid receptors.

Authors:  A N Schoffelmeer; F Hogenboom; A H Mulder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-03       Impact factor: 3.000

6.  Morphine enhances the phosphorylation of a 58 kDa protein in mouse brain membranes.

Authors:  K Nagamatsu; K Suzuki; R Teshima; H Ikebuchi; T Terao
Journal:  Biochem J       Date:  1989-01-01       Impact factor: 3.857

7.  Purification to homogeneity of an active opioid receptor from rat brain by affinity chromatography.

Authors:  S Loukas; M Mercouris; F Panetsos; C Zioudrou
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

8.  Opioid-binding protein (OBCAM) is rich in beta-sheets.

Authors:  C S Wu; J Hasegawa; A P Smith; H H Loh; N M Lee; J T Yang
Journal:  J Protein Chem       Date:  1990-02

9.  Regulation of an opioid-binding protein in NG108-15 cells parallels regulation of delta-opioid receptors.

Authors:  C M Lane; R Elde; H H Loh; N M Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

10.  Immunoblots with rhodopsin antisera suggest that a purified mu opioid binding protein has structural characteristics of a G-protein-coupled receptor.

Authors:  T L Gioannini; E R Weiss; G L Johnson; J M Hiller; E J Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.